Lynn K. Gordon;Jonathan Braun;David Telander;Madhuri Wadehra;Shawn A. Morales
发明人:
Lynn K. Gordon,Jonathan Braun,Shawn A. Morales,David Telander,Madhuri Wadehra
申请号：
US13580100
公开号：
US20130034555A1
申请日:
2011.02.22
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A method is disclosed for treating diseases or disorders of the eye involving undesired expression of vascular endothelial growth factor (VEGF) by administration of endothelial membrane protein 2 (EMP2) inhibitor. The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering an EMP2 inhibitor intraocularly or systemically.
